Pulse Biosciences, Inc. (PLSE)
Largest Insider Buys in Sector
PLSE Stock Price History Chart
PLSE Stock Performance
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in …
Insider Activity of Pulse Biosciences, Inc.
Over the last 12 months, insiders at Pulse Biosciences, Inc. have bought $2.01M and sold $871,000 worth of Pulse Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Pulse Biosciences, Inc. have bought $25.42M and sold $871,000 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DUGGAN ROBERT W () — $5.76M. Barrett Burke Thomas (President and CEO) — $85,600.
The last purchase of 55,256 shares for transaction amount of $949,298 was made by DUGGAN ROBERT W () on 2024‑12‑13.
List of Insider Buy and Sell Transactions, Pulse Biosciences, Inc.
| 2024-12-13 | 55,256 0.0882% | $17.18 | $949,298 | +5.24% | ||||
| 2024-12-11 | Sale | Former President and CEO | 50,000 0.0804% | $17.42 | $871,000 | +3.16% | ||
| 2024-12-11 | 56,054 0.0898% | $17.35 | $972,344 | +3.16% | ||||
| 2024-05-20 | President and CEO | 10,000 0.0181% | $8.56 | $85,600 | +98.84% | |||
| 2023-12-12 | 17,999 0.0321% | $9.15 | $164,691 | +23.55% | ||||
| 2023-12-11 | 90,118 0.1681% | $9.36 | $843,504 | +26.11% | ||||
| 2023-12-08 | 116,656 0.2146% | $9.54 | $1.11M | +17.07% | ||||
| 2023-12-07 | 74,852 0.1352% | $9.19 | $687,890 | +19.84% | ||||
| 2023-12-06 | 82,813 0.1516% | $9.06 | $750,286 | +23.04% | ||||
| 2023-12-05 | 66,021 0.1193% | $9.34 | $616,636 | +17.62% | ||||
| 2023-12-04 | 27,000 0.0505% | $10.38 | $280,260 | +6.78% | ||||
| 2023-12-01 | 45,600 0.0819% | $9.07 | $413,592 | +18.15% | ||||
| 2023-11-30 | 152,944 0.2765% | $9.06 | $1.39M | +17.99% | ||||
| 2023-11-29 | 218,600 0.4025% | $9.38 | $2.05M | +15.15% | ||||
| 2023-11-28 | 124,397 0.2339% | $8.98 | $1.12M | +21.05% | ||||
| 2023-11-17 | 20,241 0.037% | $6.10 | $123,470 | +64.87% | ||||
| 2023-11-16 | Chief Executive Officer | 5,393 0.0102% | $6.52 | $35,156 | +61.02% | |||
| 2023-11-15 | Chief Strategy Officer | 17,800 0.0298% | $5.90 | $105,090 | +56.85% | |||
| 2023-05-09 | 10.02M 21.7052% | $6.51 | $65.25M | -9.70% | ||||
| 2022-10-07 | Chief Strategy Officer | 30,780 0.1025% | $2.27 | $69,908 | +96.52% |
Insider Historical Profitability
| DUGGAN ROBERT W | 42328717 68.8085% | $18.33 | 46 | 0 | +1.23% | |
| Barrett Burke Thomas | Former President and CEO | 63172 0.1027% | $18.33 | 1 | 1 | |
| Zanganeh Maky | director | 106767 0.1736% | $18.33 | 17 | 0 | +19.34% |
| Levinson Mitchell E. | Chief Strategy Officer | 73027 0.1187% | $18.33 | 3 | 0 | +57.59% |
| Danahy Kevin Patrick | Chief Executive Officer | 35887 0.0583% | $18.33 | 2 | 0 | +62.61% |
Institutional Investor Ownership
| BlackRock | $9.1M | 1.71 | 1.04M | -2.51% | -$234,542.86 | <0.0001 | |
| The Vanguard Group | $7.38M | 1.38 | 847,212 | +28.76% | +$1.65M | <0.0001 | |
| Bank of America | $6.79M | 1.27 | 779,552 | -2.72% | -$189,782.19 | <0.01 | |
| Geode Capital Management | $3.41M | 0.64 | 390,959 | +3.08% | +$101,918.82 | <0.0001 | |
| State Street | $3.05M | 0.57 | 349,740 | +12.99% | +$350,316.15 | <0.0001 |